News

  1. 12/12/2012 Catalent and UMN Pharma announce collaboration for production in Japan

  2. 12/12/2012 Bio-Process Systems Alliance Elects New Director from Catalent

  3. 12/06/2012 Catalent to supply the newly approved Exelixis COMETRIQ™

  4. 11/27/2012 Oral Drug Delivery for Macromolecules Using Softgel Lipid Delivery System

  5. 11/25/2012 Faster Pipeline Progression Discussed by Catalent Expert EAC 2012

  6. 11/19/2012 Catalent Experts to Speak at Pharma Integrates 2012

  7. 11/12/2012 Catalent Announces Cell Line Sales Agreement with CEVEC Pharmaceuticals

  8. 11/08/2012 Extractable and Leachables for Biological and High Risk Dosage Forms

  9. 10/16/2012 Catalent Wins Fifth Consecutive European Outsourcing Award

  10. 10/15/2012 Catalent Announces Launch of Catalent Applied Drug Delivery Institute

  11. 10/09/2012 Catalent Licenses Technology with NJIT

  12. 10/07/2012 Catalent Present at the 2012 AAPS Annual Meeting

  13. 10/01/2012 Catalent Announces Global Alliance with PAREXEL

  14. 09/30/2012 Catalent Enters Into Commerical Supply Agreement with Vivus

  15. 09/19/2012 Catalent Expert Invited to Speak on Advanced Delivery Technologies

  16. 09/17/2012 Optimizing Clinical Supply Processes and Maximizing Budgets Presented

  17. 09/17/2012 Catalent Completes $350 Million 7.875% Senior Notes Offering

  18. 09/12/2012 Catalent and CTC Partner to Help Korean Pharma

  19. 09/05/2012 Catalent Quality Expert Presents At 2012 ICH Q10 Workshop

  20. 07/23/2012 Catalent Announces Commencement of Supply of Abilify®

  21. 07/18/2012 Expert Invited to Speak on the Advantages of Single Use Biomanufacturing

  22. 07/17/2012 Catalent Expert Will Present at PERI

  23. 07/10/2012 Catalent Expert Presents at 2012 CRS Conference

  24. 06/21/2012 Catalent Experts Present at CPhI/ICSE China 2012

  25. 06/20/2012 Catalent and Bend Provide Solutions for Controlled-Release Technologies

  26. 06/19/2012 Frazier Healthcare Acquires Packaging Operations from Catalent Pharma Solutions

  27. 06/10/2012 Catalent Expert Conducts Workshop On Solid Dosage Forms

  28. 06/04/2012 Catalent Increases Sterile Fill-Finish Manufacturing Capacity

  29. 05/29/2012 Catalent Enters Agreement to Sell Its U.S. Commercial Packaging Operations

  30. 05/15/2012 Catalent Announces Winners of Global Academic Competion

  31. 05/13/2012 Drug Delivery/Formulation Issues Identified As Concerns In Technology Survey

  32. 05/10/2012 Catalent Expert Gives Working Group Update At Conference

  33. 04/29/2012 Biosimilars Webinar Presented by Catalent Expert

  34. 04/26/2012 Case Study Presented on Achieving Biological Assay Success

  35. 04/16/2012 Catalent Expert Presents at German Pharma Congress

  36. 04/15/2012 Nascent and Catalent Sign Cancer Antibody Development Deal

  37. 04/11/2012 Two Global Catalent Experts Present at AAPS Workshop

  38. 04/10/2012 Catalent Expert To Share Formulation Development Expertise at Aerosol School

  39. 04/09/2012 Catalent Expert to Present at ISPE Japan 2012

  40. 04/03/2012 BASF and Catalent Join Forces to Solve Bioavailability Challenges

  41. 04/02/2012 Catalent Expert Presents Case Study at PDA

  42. 03/29/2012 Pharma Industry in NJ: A Panel Discussion

  43. 03/21/2012 Catalent Extends Development and Analytical Solutions Capabilities in UK

  44. 03/14/2012 Catalent Experts To Present Drug Delivery Technologies At ICSE/CPhI Japan 2012

  45. 03/11/2012 Catalent Appoints a Vice President of Commercial Excellence

  46. 03/07/2012 Expert Presents At The 5th Annual Comparator Studies Conference

  47. 03/06/2012 Catalent Continues Investment In Global Clinical Supply Services

  48. 03/01/2012 Drug Delivery Innovations Presented at 2nd Lyophilization Americas Conference

  49. 02/28/2012 Catalent Acquires 100% of R.P. Scherer - Eberbach, Germany

  50. 02/20/2012 Catalent Expert Presents on Protein Expression in CHO Cells

  51. 02/19/2012 Catalent Expert Presents Effective Global Supply Chain Solutions

  52. 02/16/2012 Catalent Completes Acquisition of Clinical Trials Supplies Business of Aptuit

  53. 02/15/2012 Catalent and NewMarket Pharmaceuticals to Develop Better Treatments

  54. 01/31/2012 Expansion Advanced Dose Form Facility In Italy Complete

  55. 01/29/2012 Catalent Acquires Current Minority Interest in R.P. Scherer, Eberbach, Germany

  56. 01/24/2012 Catalent Expands Controlled Release Drug Development & Supply

  57. 01/18/2012 Catalent Expert To Present On Virological Safety

  58. 01/17/2012 Catalent Expert To Present On Technology Delivery

  59. 01/15/2012 Catalent Expert to Present Strategies for Improved Oral Delivery

  60. 01/03/2012 Catalent Expert to Present at Peptalk 2012